A Novel Biosignature Identifies Patients With DCIS With High Risk of Local Recurrence After Breast Conserving Surgery and Radiation Therapy

Overview of attention for article published in International Journal of Radiation Oncology, Biology, Physics, September 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

So far, Altmetric has seen 11 X posts from 10 X users, with an upper bound of 9,417 followers.

RT @PreludeDx: #PreludeDx was honored to have its #DCISionRT test discussed in a plenary session at #MBCC24. @DrShelleyHwang from @DukeCanc…

RT @PreludeDx: #PreludeDx was honored to have its #DCISionRT test discussed in a plenary session at #MBCC24. @DrShelleyHwang from @DukeCanc…

#PreludeDx was honored to have its #DCISionRT test discussed in a plenary session at #MBCC24. @DrShelleyHwang from @DukeCancer discussed the results presented in @IJROBP – The Red Journal. To read the journal article https://t.co/tSpyFAWO5C #bcsm https://t

RT @CalhounBC_Path: @UNC_Lineberger @UNCPathology p63, myosin, cytokeratin AE1/AE3. More on DCISionRT (I had not received a request for it…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 7 additional X posts.